miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma

Table 2

Clinical characteristics and expressions of miR-876 in 127 HCC patients.

Parameters	Total case	miR-876
		High	Low	value
All case	127	63	64
Gender				0.610
Male	22	12	10
Female	105	51	54
Age (years)				0.129
≥60	25	9	16
<60	102	54	48
Tumor size (cm)				0.135
>5	96	44	52
≤5	31	19	12
Tumor number				0.728
Multiple	34	16	18
Single	93	47	46
HBsAg				0.101
Yes	111	52	59
No	16	11	5
AFP				0.535
>400	64	30	34
≤400	63	33	30
Liver cirrhosis				0.026
Yes	61	24	37
No	66	39	27
Child stage				0.324
A	118	57	61
B	9	6	3
Tumor thrombus				0.031
Yes	26	8	18
No	101	55	46
Stage (UICC)				0.021
I-II	78	45	33
III-IV	49	18	31

Fisher’s exact test.